Stay updated on Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page.

Latest updates to the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the related topics section. No core content or functionality of the study page was changed.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded the updated DREAMM-7 publication citation (Lancet Oncology 2025) with the updated overall survival analysis and related erratum details, replacing the prior entry.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the page.SummaryDifference0.0%

- Check46 days agoChange DetectedAdded a new publication reference for DREAMM-7 updated overall survival in Lancet Oncol (2025) to the Publications section. Removed the disease keyword 'Multiple myeloma' and related topics from the keywords/related topics.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1. No substantive study content changes are evident.SummaryDifference0.0%

- Check60 days agoChange DetectedThe change involves updating the revision label from v3.4.0 to v3.4.1, which does not alter the study details or page functionality; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab vs Daratumumab in Multiple Myeloma Clinical Trial page.